The company reported its second late-stage study success, this time with a drug that could become a new treatment standard ...

Imagine living with unexplained changes and health issues for nearly a decade, only to discover it's a rare disease that was, until recently, very difficult to treat and can affect nearly every aspect ...

BridgeBio reports second late-stage rare disease drug success, establishing new treatment potential for endocrine disorder ...

Endocrine diseases of any type — not just diabetes — can represent a cardiovascular risk and patients with those disorders should be screened for high cholesterol, according to a new clinical practice ...

Credit: Getty Images We spoke with endocrinologists to explore the potential of artificial intelligence in the management of chronic disease, including diabetes, obesity, and PCOS. Artificial ...

CARMEL, Ind.--(BUSINESS WIRE)--MBX Biosciences, a drug discovery company focused in rare endocrine diseases, today announced the closing of a $34.6 million Series A financing. The financing was led by ...

Endogenous Cushing's syndrome is a severe, potentially lethal, endocrine condition. It is well known for its pleomorphic ...

PUTEAUX, France--(BUSINESS WIRE)--Recordati Rare Diseases announces that positive results from the Phase III LINC 4 study of Isturisa® were presented on March 22 at The Endocrine Society’s Annual ...

Denmark-based Ascendis Pharma has nearly doubled its New Jersey footprint with the opening of an expanded Princeton office.

Verzenio plus endocrine therapy reduced death risk by 15.8% in high-risk early breast cancer patients compared to endocrine ...